Written question asked by Kerry McCarthy (Labour) on Thursday, 3 September 2020, in the House of Commons. It was due for an answer on Tuesday, 8 September 2020 (named day). A holding answer was provided on Tuesday, 8 September 2020. A substantive answer was provided by Jo Churchill (Conservative) on Tuesday, 15 September 2020 on behalf of the Department of Health and Social Care.

---

Members: Correspondence

Question

To ask the Secretary of State for Health and Social Care, with reference to his meeting with the hon. Member for Bristol East's constituent Jake Ogborne on access to the drug Spinraza on 23 June, and his response to the hon. Members for Bristol East's question in the House on 20 July, Official Report, column 1857, when he will provide the hon. Member with details of his correspondence with NHS England on access to Spinraza.

Answer

The Secretary of State for Health and Social Care has discussed access to Spinraza with NHS England and NHS Improvement. My Rt hon. Friend has asked them to respond to the hon. Member for Bristol East as soon as possible.

---

Secondary information

Type

Written question

Reference

84657

Session

2019-21

Subjects

Correspondence Members NHS England Nusinersen

Link

View this Written question on www.parliament.uk